Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related portfolio, has highlighted the ongoing difficulties Americans face in accessing branded GLP-1 medications. To address the issue, the company launched a GLP-1 Supply Tracker, allowing individuals to report their experiences and advocate for improved access to essential medication. The move comes despite last week’s update when the FDA revised its shortage list to note that the .25
Health
